NASDAQ: FBLGFibrobiologics Inc Stock Ownership - Who owns Fibrobiologics?
Insider buying vs selling
Have Fibrobiologics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Hamid Khoja | Chief Scientific Officer | 2026-03-04 | 30,000 | $0.38 | $11.40kBuy |
| Pete Oheeron | CHIEF EXECUTIVE OFFICER | 2026-03-04 | 15,872 | $0.38 | $6.00kBuy |
| Pete Oheeron | CHIEF EXECUTIVE OFFICER | 2026-03-03 | 18,200 | $0.41 | $7.37kBuy |
| Jason Davis | Chief Financial Officer | 2026-03-02 | 70,000 | $0.41 | $28.98kBuy |
| Pete Oheeron | CHIEF EXECUTIVE OFFICER | 2026-03-02 | 17,428 | $0.35 | $6.15kBuy |
| Ruben A. Garcia | General Counsel | 2026-02-27 | 40,000 | $0.33 | $13.04kBuy |
| Ruben A. Garcia | General Counsel | 2025-12-11 | 140,000 | $0.34 | $47.60kBuy |
FBLG insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when FBLG insiders and whales buy or sell their stock.
FBLG Shareholders
What type of owners hold Fibrobiologics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Pete Oheeron | 89.49% | 5,958,147 | $6.08M | Insider |
| Ruben A. Garcia | 2.70% | 180,000 | $183.60k | Insider |
| Richard C. Cilento Jr. | 1.40% | 93,225 | $95.09k | Insider |
| Jason Davis | 1.05% | 70,000 | $71.40k | Insider |
| Vanguard Capital Management LLC | 1.02% | 67,665 | $69.02k | Institution |
| Hamid Khoja | 0.92% | 61,250 | $62.48k | Insider |
| Fund Evaluation Group LLC | 0.78% | 51,794 | $52.83k | Institution |
| Geode Capital Management LLC | 0.44% | 29,609 | $30.20k | Institution |
| Blackrock Inc | 0.37% | 24,647 | $25.14k | Institution |
| Cascade Financial Partners LLC | 0.25% | 16,428 | $16.76k | Institution |
FBLG vs Biotech Stocks
Fibrobiologics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.